Fingerprint Fingerprint is based on mining the text of the persons scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 23 Similar Profiles
Lymphoma Medicine & Life Sciences
Follicular Lymphoma Medicine & Life Sciences
Mantle-Cell Lymphoma Medicine & Life Sciences
B-Cell Lymphoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
T-Lymphocytes Medicine & Life Sciences
Lymphoma, Large B-Cell, Diffuse Medicine & Life Sciences
Hodgkin Disease Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2001 2018

25 Citations

Chimeric antigen receptor T-cell therapy-assessment and management of toxicities

Neelapu, S. S., Tummala, S., Kebriaei, P., Wierda, W., Gutierrez, C., Locke, F. L., Komanduri, K. V., Lin, Y., Jain, N., Daver, N., Westin, J., Gulbis, A. M., Loghin, M. E., De Groot, J. F., Adkins, S., Davis, S. E., Rezvani, K., Hwu, P. & Shpall, E. J. Jan 1 2018 In : Nature Reviews Clinical Oncology. 15, 1, p. 47-62 16 p.

Research output: Contribution to journalReview article

Adoptive Immunotherapy
Antigen Receptors
Brain Diseases
Cell- and Tissue-Based Therapy
T-Cell Antigen Receptor
Follicular Lymphoma
Disease-Free Survival
Lymphoma, Large B-Cell, Diffuse
Vincristine
Prednisone

Novel baff-receptor antibody to natively folded recombinant protein eliminates drug-resistant human b-cell malignancies in vivo

Qin, H., Wei, G., Sakamaki, I., Dong, Z., Cheng, W. A., Lynne Smith, D., Wen, F., Sun, H., Kim, K., Cha, S., Bover, L., Neelapu, S. S. & Kwak, L. W. Mar 1 2018 In : Clinical Cancer Research. 24, 5, p. 1114-1123 10 p.

Research output: Contribution to journalArticle

Recombinant Proteins
Antibodies
Pharmaceutical Preparations
B-Lymphocytes
Neoplasms

Phase 2 trial of bortezomib in combination with rituximab plus hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with bortezomib, rituximab, methotrexate, and cytarabine for untreated mantle cell lymphoma

Romaguera, J. E. , Wang, M. , Feng, L. , Fayad, L. E. , Hagemeister, F. , Mclaughlin, P. , Rodriguez, M. A. , Fanale, M. , Orlowski, R. , Kwak, L. W. , Neelapu, S. , Oki, Y. , Pro, B. , Younes, A. , Samaniego, F. , Fowler, N. , Hartig, K. , Valentinetti, M. , Smith, J. , Ford, P. & 4 others Naig, A., Medeiros, L. J., Kantarjian, H. M. & Goy, A. Jan 1 2018 (Accepted/In press) In : Cancer.

Research output: Contribution to journalArticle

Mantle-Cell Lymphoma
Cytarabine
Vincristine
Methotrexate
Doxorubicin

Phase I study of an active immunotherapy for asymptomatic phase Lymphoplasmacytic lymphoma with DNA vaccines encoding antigen-chemokine fusion: Study protocol

Thomas, S. K., Cha, S. C., Smith, D. L., Kim, K. H., Parshottam, S. R., Rao, S., Popescu, M., Lee, V. Y., Neelapu, S. S. & Kwak, L. W. Feb 13 2018 In : BMC cancer. 18, 1, 187

Research output: Contribution to journalArticle

Active Immunotherapy
DNA Vaccines
Chemokines
Lymphoma
Antigens